Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

NAFCILLIN SODIUM

NAFCILLIN SODIUM

Standard Dose
EQ 4GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NAFCILLIN SODIUM is listed in Drugs@FDA under application 062844 (ANDA).

Marketing status: Discontinued Active ingredient NAFCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 4GM BASE/VIAL Sponsor WATSON LABS INC Submission history Latest submission status date: 2000-12-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview NAFCILLIN SODIUM is listed in Drugs@FDA under application 062844 (ANDA). Marketing status: Discontinued Active ingredient NAFCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 4GM BASE/VIAL Sponsor WATSON LABS INC Submission history Latest submission status date: 2000-12-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
NAFCILLIN SODIUM (NAFCILLIN SODIUM) | Drug Monograph | MedicHelpline